Quaker Chemical Co. (NYSE:KWR) Shares Sold by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company cut its stake in shares of Quaker Chemical Co. (NYSE:KWR) by 6.0% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 7,760 shares of the specialty chemicals company’s stock after selling 494 shares during the period. The Manufacturers Life Insurance Company’s holdings in Quaker Chemical were worth $1,307,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in KWR. Fifth Third Bancorp raised its stake in shares of Quaker Chemical by 36.8% during the 2nd quarter. Fifth Third Bancorp now owns 286 shares of the specialty chemicals company’s stock worth $49,000 after buying an additional 77 shares in the last quarter. GAMMA Investing LLC increased its stake in Quaker Chemical by 105.3% in the 3rd quarter. GAMMA Investing LLC now owns 156 shares of the specialty chemicals company’s stock valued at $26,000 after purchasing an additional 80 shares in the last quarter. Louisiana State Employees Retirement System increased its stake in Quaker Chemical by 1.4% in the 2nd quarter. Louisiana State Employees Retirement System now owns 7,000 shares of the specialty chemicals company’s stock valued at $1,188,000 after purchasing an additional 100 shares in the last quarter. Mackenzie Financial Corp grew its holdings in Quaker Chemical by 6.6% during the 2nd quarter. Mackenzie Financial Corp now owns 1,778 shares of the specialty chemicals company’s stock valued at $302,000 after buying an additional 110 shares during the last quarter. Finally, Nisa Investment Advisors LLC grew its holdings in Quaker Chemical by 1.0% during the 3rd quarter. Nisa Investment Advisors LLC now owns 13,001 shares of the specialty chemicals company’s stock valued at $2,191,000 after buying an additional 123 shares during the last quarter. 77.46% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on KWR shares. Deutsche Bank Aktiengesellschaft decreased their price objective on Quaker Chemical from $190.00 to $182.00 and set a “buy” rating on the stock in a report on Monday, November 4th. Piper Sandler raised their price objective on Quaker Chemical from $190.00 to $200.00 and gave the stock an “overweight” rating in a report on Friday, November 8th. StockNews.com upgraded Quaker Chemical from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Finally, Royal Bank of Canada decreased their price objective on Quaker Chemical from $195.00 to $180.00 and set an “outperform” rating on the stock in a report on Monday, November 4th.

Insider Transactions at Quaker Chemical

In related news, SVP David Slinkman sold 1,700 shares of the business’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $167.80, for a total transaction of $285,260.00. Following the sale, the senior vice president now owns 2,825 shares of the company’s stock, valued at $474,035. The trade was a 37.57 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Jeewat Bijlani sold 645 shares of the business’s stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $165.98, for a total value of $107,057.10. Following the sale, the executive vice president now directly owns 4,747 shares in the company, valued at approximately $787,907.06. The trade was a 11.96 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.30% of the company’s stock.

Quaker Chemical Stock Down 1.0 %

Shares of NYSE KWR opened at $154.65 on Wednesday. The firm has a market cap of $2.75 billion, a price-to-earnings ratio of 22.68, a PEG ratio of 1.89 and a beta of 1.38. Quaker Chemical Co. has a 1 year low of $151.31 and a 1 year high of $221.94. The stock’s 50-day simple moving average is $161.41 and its 200-day simple moving average is $167.21. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.88 and a current ratio of 2.54.

Quaker Chemical (NYSE:KWR) last issued its earnings results on Thursday, October 31st. The specialty chemicals company reported $1.89 EPS for the quarter, missing analysts’ consensus estimates of $2.08 by ($0.19). Quaker Chemical had a net margin of 6.58% and a return on equity of 10.10%. The company had revenue of $462.27 million during the quarter, compared to analyst estimates of $469.17 million. During the same quarter in the previous year, the firm earned $2.05 earnings per share. The business’s revenue was down 5.8% on a year-over-year basis. As a group, equities analysts anticipate that Quaker Chemical Co. will post 7.78 earnings per share for the current fiscal year.

Quaker Chemical Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, January 17th will be given a dividend of $0.485 per share. The ex-dividend date of this dividend is Friday, January 17th. This represents a $1.94 annualized dividend and a dividend yield of 1.25%. Quaker Chemical’s dividend payout ratio is presently 28.45%.

Quaker Chemical Profile

Quaker Chemical Corporation, together with its subsidiaries, develops, produces, and markets various formulated specialty chemical products for a range of heavy industrial and manufacturing applications in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals.